| Advice Pool |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Insurance > Health > Uninsured Americans Routinely Charged More For Medical Treatment |
|
Advice Pool - Uninsured Americans Routinely Charged More For Medical Treatment
If you are one of the 46.6 million Americans that have joined the ranks of the uninsured, what you may not know is that you According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product may have to pay more for your medical treatment than your privately insured counterparts. If those without insurance get s ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ick, they usually have to pay much more for the same medical services, since insurance companies can negotiate discounts wi lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. th doctors, hospitals, pharmacies, and others health care providers. This means that the average uninsured working man or here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe oman who suffers a mild heart attack can be stuck with a hospital bill that is in excess of $30,000 compared to the $10,000 d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro , negotiated rate, which is charged to an insured patient’s private insurance carrier. In many cases, uninsured individuals ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc are charged 3-4 times more for the exact same medical treatment that is administered to patients with private insurance. easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi dditionally, uninsured patient with huge medical bills are usually aggressively pursued by collection agencies and new bank nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ruptcy laws make it extremely difficult to discharge medical debt. If you don’t have health insurance coverage, you have a and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ 25% greater chance of developing a life-threatening disease or condition than those with health insurance. Here are some st ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi rtling statistics from the National Institute of Medicine (OIM) – an arm of the National Academy of Sciences: 1. Lack of h ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ealth insurance causes 18,000 unnecessary deaths per year 2. Adults without health insurance coverage have a 25% greater c dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod hance of dying from a disease or condition than those with health insurance coverage 3. The nation spends $65 to $130 bill cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ion a year in lost resources because of diminished health and premature deaths relating to uninsured Americans Today, ther tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen are more uninsured Americans than any point in history. According to the U.S. Census Bureau, approximately 15.9 percent of t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel Americans are walking around without health insurance coverage and paying for medical expenses out of pocket. Although tre ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust atment for a sore throat or broken ankle can be a manageable medical expense for some families, more expensive treatments l y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ke surgery or chemotherapy can be financially devastating. If you are the type of person that wouldn’t risk driving your ve . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de hicle without car insurance, consider the fact that there is a statistically greater chance that you will suffer from an il elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip lness or injury than an auto accident. ©2007 Small Business Insurance Services, Inc. www.smallbusinessinsuranceservices.co tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Residual Income In An Affiliate Program How To Find Sources Online Who Sell Niche Products Wholesale
|